Solanezumab Active Not Recruiting Phase 3 Trials for Cognition Disorders Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02008357Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss